NYSE: PATH

Uipath Inc Stock Forecast, Predictions & Price Target

The consensus among 16 Wall Street analysts covering (NYSE: PATH) stock is to Buy PATH stock.

Out of 16 analysts, 5 (31.25%) are recommending PATH as a Strong Buy, 2 (12.5%) are recommending PATH as a Buy, 9 (56.25%) are recommending PATH as a Hold, 0 (0%) are recommending PATH as a Sell, and 0 (0%) are recommending PATH as a Strong Sell.

If you're new to stock investing, here's how to buy Uipath stock.

(NYSE: PATH) Uipath's forecast annual revenue growth rate of 15.12% is forecast to beat the US Software - Infrastructure industry's average forecast revenue growth rate of 11.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Uipath's revenue in 2024 is $1,308,072,000.On average, 6 Wall Street analysts forecast PATH's revenue for 2025 to be $862,343,765,606, with the lowest PATH revenue forecast at $744,307,863,014, and the highest PATH revenue forecast at $886,407,293,955. On average, 5 Wall Street analysts forecast PATH's revenue for 2026 to be $1,011,904,085,260, with the lowest PATH revenue forecast at $885,855,352,065, and the highest PATH revenue forecast at $1,050,248,683,235.

In 2027, PATH is forecast to generate $1,122,282,789,910 in revenue, with the lowest revenue forecast at $1,032,780,006,945 and the highest revenue forecast at $1,211,785,572,875.

According to 16 Wall Street analysts that have issued a 1 year PATH price target, the average PATH price target is $27.44, with the highest PATH stock price forecast at $32.00 and the lowest PATH stock price forecast at $24.00.

On average, Wall Street analysts predict that Uipath's share price could reach $27.44 by Apr 8, 2025. The average Uipath stock price prediction forecasts a potential upside of 45.25% from the current PATH share price of $18.89.

(NYSE: PATH) forecast ROE is N/A, which is considered weak.